| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6114459 | Autoimmunity Reviews | 2015 | 5 Pages |
Abstract
By Medline research we collected important data dealing with potential anti-thrombotic effects of HCQ. The mechanisms of action of HCQ, and clinical and experimental data in systemic lupus erythematosus (SLE) and APS are discussed. As HCQ reduces the risk of thrombosis in both SLE patients and animal models of APS (1-7), and possibly decreases the titre of aPL [8], its beneficial role as a potential antithrombotic could be suggested.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Cristina Belizna,